Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Mereo BioPharma Group PLC ADR Share Price

MREO

NAQ

$0.3719

-$0.02

(-5.15%)

Industry: Biotechnology Sector: Health Care

Mereo BioPharma Group PLC ADR Analyst Forecast

Overview Returns Financials Ratios News FAQs

Mereo BioPharma Group PLC ADR Share Price Chart

Mereo BioPharma Group PLC ADR Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$61.85M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

1.88M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.26

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$0.2 L

$3.05 H

$0.3719

About Mereo BioPharma Group PLC ADR, Common Stock

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab, an antibody for the treatment of osteogenesis imperfecta; and Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom. more

Industry: BiotechnologySector: Health Care

Mereo BioPharma Group PLC ADR Stock Returns

Time Frame	MREO	Sector	S&P500
1-Week Return	-11.94%	-1.08%	-1.38%
1-Month Return	-43.36%	-0.47%	-1.81%
3-Month Return	-79%	2.13%	1.38%
6-Month Return	-78.39%	17.04%	5.68%
1-Year Return	-87.02%	6.56%	11.74%
3-Year Return	-64.06%	16.78%	65.15%
5-Year Return	-89.26%	34.34%	73.68%
10-Year Return	-94.25%	137.88%	260.03%

Time Frame	MREO	Sector	S&P500
1-Week Return	-99.87%	-43.23%	-51.55%
1-Month Return	-99.90%	-5.57%	-19.93%
3-Month Return	-99.82%	8.92%	5.72%
6-Month Return	-95.52%	37.58%	11.85%
1-Year Return	-87.02%	6.56%	11.74%
3-Year Return	-28.90%	5.31%	18.20%
5-Year Return	-36.00%	6.08%	11.67%
10-Year Return	-24.84%	9.05%	13.67%

Mereo BioPharma Group PLC ADR Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	393.00K	49.21M	1.51M	10.00M	-	[{"date":"2020-12-31","value":0.8,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":3.06,"profit":true},{"date":"2023-12-31","value":20.32,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	2.05M	24.17M	(257.44K)	2.57M	1.09M	[{"date":"2020-12-31","value":8.48,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1.07,"profit":false},{"date":"2023-12-31","value":10.65,"profit":true},{"date":"2024-12-31","value":4.5,"profit":true}]
Gross Profit	(2.05M)	25.04M	257.44K	7.43M	(1.09M)	[{"date":"2020-12-31","value":-8.19,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":1.03,"profit":true},{"date":"2023-12-31","value":29.65,"profit":true},{"date":"2024-12-31","value":-4.35,"profit":false}]
Gross Margin	(521.75%)	50.89%	17.08%	74.26%	-	[{"date":"2020-12-31","value":-702.6,"profit":false},{"date":"2021-12-31","value":68.53,"profit":true},{"date":"2022-12-31","value":23,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	46.13M	53.30M	53.92M	35.84M	47.36M	[{"date":"2020-12-31","value":85.54,"profit":true},{"date":"2021-12-31","value":98.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.47,"profit":true},{"date":"2024-12-31","value":87.83,"profit":true}]
Operating Income	(48.18M)	(28.26M)	(53.67M)	(28.42M)	(47.36M)	[{"date":"2020-12-31","value":-4817678000,"profit":false},{"date":"2021-12-31","value":-2825599914,"profit":false},{"date":"2022-12-31","value":-5366743000,"profit":false},{"date":"2023-12-31","value":-2841600000,"profit":false},{"date":"2024-12-31","value":-4736400000,"profit":false}]
Total Non-Operating Income/Expense	(171.61M)	43.46M	6.54M	(2.33M)	5.78M	[{"date":"2020-12-31","value":-394.91,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.06,"profit":true},{"date":"2023-12-31","value":-5.37,"profit":false},{"date":"2024-12-31","value":13.31,"profit":true}]
Pre-Tax Income	(213.45M)	19.22M	(44.46M)	(30.00M)	(43.25M)	[{"date":"2020-12-31","value":-1110.54,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-231.31,"profit":false},{"date":"2023-12-31","value":-156.08,"profit":false},{"date":"2024-12-31","value":-225.04,"profit":false}]
Income Taxes	(3.62M)	2.05M	(2.34M)	(532.00K)	18.20K	[{"date":"2020-12-31","value":-176.87,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-114.2,"profit":false},{"date":"2023-12-31","value":-26,"profit":false},{"date":"2024-12-31","value":0.89,"profit":true}]
Income After Taxes	(209.83M)	17.17M	(42.12M)	(29.47M)	(43.27M)	[{"date":"2020-12-31","value":-1221.77,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-245.26,"profit":false},{"date":"2023-12-31","value":-171.57,"profit":false},{"date":"2024-12-31","value":-251.96,"profit":false}]

Income From Continuous Operations	(163.63M)	12.72M	(34.20M)	(29.47M)	(43.25M)	[{"date":"2020-12-31","value":-1285.88,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-268.73,"profit":false},{"date":"2023-12-31","value":-231.56,"profit":false},{"date":"2024-12-31","value":-339.91,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(209.83M)	17.17M	(42.12M)	(29.47M)	(43.25M)	[{"date":"2020-12-31","value":-1221.77,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-245.26,"profit":false},{"date":"2023-12-31","value":-171.57,"profit":false},{"date":"2024-12-31","value":-251.85,"profit":false}]

EPS (Diluted)	(3.66)	-	(0.16)	(0.04)	(0.18)	[{"date":"2020-12-31","value":-365.63,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-15.93,"profit":false},{"date":"2023-12-31","value":-3.5,"profit":false},{"date":"2024-12-31","value":-18.01,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	12422.43%	(96.94%)	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.78,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	1078.71%	(101.07%)	-	(57.71%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-9.37,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-5.35,"profit":false}]
Gross Profit	-	(1321.36%)	(98.97%)	-	(114.66%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Gross Margin	-	(109.75%)	(66.43%)	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	15.55%	1.17%	-	32.15%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":48.38,"profit":true},{"date":"2022-12-31","value":3.65,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	(41.35%)	89.93%	-	66.68%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-45.98,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":74.15,"profit":true}]
Total Non-Operating Income/Expense	-	(125.32%)	(84.94%)	-	(347.94%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Pre-Tax Income	-	(109.00%)	(331.31%)	-	44.19%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-246.69,"profit":false},{"date":"2022-12-31","value":-749.81,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	(156.54%)	(214.20%)	-	(103.42%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Income After Taxes	-	(108.18%)	(345.26%)	-	46.85%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-230.91,"profit":false},{"date":"2022-12-31","value":-736.94,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Income From Continuous Operations	-	(107.78%)	(368.73%)	-	46.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-230.34,"profit":false},{"date":"2022-12-31","value":-788.06,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(108.18%)	(345.26%)	-	46.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-231.22,"profit":false},{"date":"2022-12-31","value":-737.91,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	-	414.57%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	1.06M	-	500.00K	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":46.98,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	284.89K	271.46K	271.04K	132.00K	1.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":95.28,"profit":true},{"date":"2025-03-31","value":95.14,"profit":true},{"date":"2025-06-30","value":46.33,"profit":true},{"date":"2025-09-30","value":0.35,"profit":true}]
Gross Profit	(284.89K)	(271.46K)	(271.04K)	368.00K	(1.00K)	[{"date":"2024-09-30","value":-77.42,"profit":false},{"date":"2024-12-31","value":-73.77,"profit":false},{"date":"2025-03-31","value":-73.65,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.27,"profit":false}]
Gross Margin	-	(25.51%)	-	73.60%	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-34.66,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	9.37M	14.86M	11.20M	10.87M	10.01M	[{"date":"2024-09-30","value":63.07,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":75.37,"profit":true},{"date":"2025-06-30","value":73.12,"profit":true},{"date":"2025-09-30","value":67.38,"profit":true}]
Operating Income	(9.37M)	(15.13M)	(11.20M)	(10.50M)	(10.02M)	[{"date":"2024-09-30","value":-937300000,"profit":false},{"date":"2024-12-31","value":-1513336800,"profit":false},{"date":"2025-03-31","value":-1120200000,"profit":false},{"date":"2025-06-30","value":-1049900000,"profit":false},{"date":"2025-09-30","value":-1001500000,"profit":false}]
Total Non-Operating Income/Expense	(5.00M)	8.09M	(1.21M)	(3.55M)	3.47M	[{"date":"2024-09-30","value":-61.79,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-14.91,"profit":false},{"date":"2025-06-30","value":-43.92,"profit":false},{"date":"2025-09-30","value":42.87,"profit":true}]
Pre-Tax Income	(15.00M)	(7.55M)	(12.89M)	(14.62M)	(7.02M)	[{"date":"2024-09-30","value":-1500100000,"profit":false},{"date":"2024-12-31","value":-755132700,"profit":false},{"date":"2025-03-31","value":-1288700000,"profit":false},{"date":"2025-06-30","value":-1461600000,"profit":false},{"date":"2025-09-30","value":-702400000,"profit":false}]
Income Taxes	(15.00M)	(570.66K)	-	-	-	[{"date":"2024-09-30","value":-1500100000,"profit":false},{"date":"2024-12-31","value":-57065900,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	(6.98M)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(15.00M)	(7.05M)	(12.89M)	(14.62M)	(7.02M)	[{"date":"2024-09-30","value":-1500100000,"profit":false},{"date":"2024-12-31","value":-704600000,"profit":false},{"date":"2025-03-31","value":-1288700000,"profit":false},{"date":"2025-06-30","value":-1461600000,"profit":false},{"date":"2025-09-30","value":-702400000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(15.00M)	(6.98M)	(12.89M)	(14.62M)	(7.02M)	[{"date":"2024-09-30","value":-1500100000,"profit":false},{"date":"2024-12-31","value":-698066800,"profit":false},{"date":"2025-03-31","value":-1288700000,"profit":false},{"date":"2025-06-30","value":-1461600000,"profit":false},{"date":"2025-09-30","value":-702400000,"profit":false}]

EPS (Diluted)	(0.02)	(0.01)	(0.02)	(0.02)	(0.01)	[{"date":"2024-09-30","value":-2,"profit":false},{"date":"2024-12-31","value":-1,"profit":false},{"date":"2025-03-31","value":-1.51,"profit":false},{"date":"2025-06-30","value":-2,"profit":false},{"date":"2025-09-30","value":-1,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	(4.72%)	(0.16%)	(51.30%)	(99.24%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Gross Profit	-	(4.72%)	(0.16%)	(235.78%)	(100.27%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	58.56%	(24.63%)	(2.99%)	(7.85%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-42.05,"profit":false},{"date":"2025-06-30","value":-5.11,"profit":false},{"date":"2025-09-30","value":-13.4,"profit":false}]
Operating Income	-	61.46%	(25.98%)	(6.28%)	(4.61%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-42.27,"profit":false},{"date":"2025-06-30","value":-10.21,"profit":false},{"date":"2025-09-30","value":-7.5,"profit":false}]
Total Non-Operating Income/Expense	-	(261.83%)	(114.91%)	194.53%	(197.61%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-134.6,"profit":false},{"date":"2025-03-31","value":-59.07,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-101.58,"profit":false}]
Pre-Tax Income	-	(49.66%)	70.66%	13.42%	(51.94%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-70.28,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":18.99,"profit":true},{"date":"2025-09-30","value":-73.51,"profit":false}]
Income Taxes	-	(96.20%)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	(53.03%)	82.90%	13.42%	(51.94%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-63.97,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":16.18,"profit":true},{"date":"2025-09-30","value":-62.66,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(53.47%)	84.61%	13.42%	(51.94%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-63.19,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":15.86,"profit":true},{"date":"2025-09-30","value":-61.39,"profit":false}]

EPS (Diluted)	-	(50.00%)	51.00%	32.45%	(50.00%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-98.04,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":63.63,"profit":true},{"date":"2025-09-30","value":-98.04,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	40.65M	134.32M	75.20M	63.76M	74.76M	[{"date":"2020-12-31","value":30.27,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":55.98,"profit":true},{"date":"2023-12-31","value":47.47,"profit":true},{"date":"2024-12-31","value":55.66,"profit":true}]
Non-current Assets	45.43M	36.64M	2.22M	2.74M	1.63M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":80.65,"profit":true},{"date":"2022-12-31","value":4.88,"profit":true},{"date":"2023-12-31","value":6.03,"profit":true},{"date":"2024-12-31","value":3.58,"profit":true}]
Total Assets	86.08M	170.96M	77.41M	66.50M	76.39M	[{"date":"2020-12-31","value":50.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":45.28,"profit":true},{"date":"2023-12-31","value":38.9,"profit":true},{"date":"2024-12-31","value":44.68,"profit":true}]

Total Liabilities
Current Liabilities	11.71M	16.96M	24.38M	9.49M	13.85M	[{"date":"2020-12-31","value":48.05,"profit":true},{"date":"2021-12-31","value":69.58,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":38.92,"profit":true},{"date":"2024-12-31","value":56.81,"profit":true}]
Non-current Liabilities	94.84M	34.99M	1.64M	6.48M	1.57M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":36.89,"profit":true},{"date":"2022-12-31","value":1.72,"profit":true},{"date":"2023-12-31","value":6.83,"profit":true},{"date":"2024-12-31","value":1.66,"profit":true}]
Total Liabilities	106.55M	51.95M	26.01M	15.96M	15.42M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":48.75,"profit":true},{"date":"2022-12-31","value":24.41,"profit":true},{"date":"2023-12-31","value":14.98,"profit":true},{"date":"2024-12-31","value":14.47,"profit":true}]

Total Shareholders' equity
Common Stock	1.39M	2.37M	2.48M	2.77M	3.06M	[{"date":"2020-12-31","value":45.46,"profit":true},{"date":"2021-12-31","value":77.58,"profit":true},{"date":"2022-12-31","value":81.01,"profit":true},{"date":"2023-12-31","value":90.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(423.51M)	(401.60M)	(404.57M)	(419.63M)	(462.88M)	[{"date":"2020-12-31","value":-42351179400,"profit":false},{"date":"2021-12-31","value":-40159573700,"profit":false},{"date":"2022-12-31","value":-40457500000,"profit":false},{"date":"2023-12-31","value":-41963000000,"profit":false},{"date":"2024-12-31","value":-46288300000,"profit":false}]
Other Stockholders' Equity	221.24M	334.65M	475.19M	484.88M	539.64M	[{"date":"2020-12-31","value":41,"profit":true},{"date":"2021-12-31","value":62.01,"profit":true},{"date":"2022-12-31","value":88.06,"profit":true},{"date":"2023-12-31","value":89.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	(20.47M)	119.01M	51.40M	50.54M	60.97M	[{"date":"2020-12-31","value":-17.2,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":43.19,"profit":true},{"date":"2023-12-31","value":42.47,"profit":true},{"date":"2024-12-31","value":51.23,"profit":true}]

Total Liabilities & Shareholders Equity	86.08M	170.96M	77.41M	66.50M	76.39M	[{"date":"2020-12-31","value":50.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":45.28,"profit":true},{"date":"2023-12-31","value":38.9,"profit":true},{"date":"2024-12-31","value":44.68,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	230.41%	(44.02%)	-	17.26%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-19.1,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":7.49,"profit":true}]
Non-current Assets	-	(19.35%)	(93.95%)	-	(40.60%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Total Assets	-	98.60%	(54.72%)	-	14.87%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-55.5,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":15.09,"profit":true}]

Total Liabilities
Current Liabilities	-	44.79%	43.73%	-	45.98%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":97.41,"profit":true},{"date":"2022-12-31","value":95.09,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	(63.11%)	(95.32%)	-	(75.71%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Total Liabilities	-	(51.25%)	(49.93%)	-	(3.39%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	70.65%	4.41%	-	10.23%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":6.24,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":14.49,"profit":true}]
Retained Earnings	-	(5.17%)	0.74%	-	10.31%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-50.21,"profit":false},{"date":"2022-12-31","value":7.2,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	51.26%	42.00%	-	11.29%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.94,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":22.04,"profit":true}]
Total Shareholders' equity	-	(681.28%)	(56.81%)	-	20.64%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-3300.42,"profit":false},{"date":"2022-12-31","value":-275.2,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	98.60%	(54.72%)	-	14.87%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-55.5,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":15.09,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	86.72M	74.76M	66.90M	61.42M	52.41M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":86.21,"profit":true},{"date":"2025-03-31","value":77.14,"profit":true},{"date":"2025-06-30","value":70.82,"profit":true},{"date":"2025-09-30","value":60.43,"profit":true}]
Non-current Assets	2.02M	1.63M	1.42M	1.21M	1.20M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":80.43,"profit":true},{"date":"2025-03-31","value":70.34,"profit":true},{"date":"2025-06-30","value":59.81,"profit":true},{"date":"2025-09-30","value":59.07,"profit":true}]
Total Assets	88.75M	76.39M	68.32M	62.63M	53.60M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":86.08,"profit":true},{"date":"2025-03-31","value":76.99,"profit":true},{"date":"2025-06-30","value":70.57,"profit":true},{"date":"2025-09-30","value":60.4,"profit":true}]

Total Liabilities
Current Liabilities	14.21M	13.85M	7.50M	7.56M	6.02M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.47,"profit":true},{"date":"2025-03-31","value":52.77,"profit":true},{"date":"2025-06-30","value":53.19,"profit":true},{"date":"2025-09-30","value":42.34,"profit":true}]
Non-current Liabilities	2.00M	1.57M	744.00K	897.00K	988.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":78.57,"profit":true},{"date":"2025-03-31","value":37.16,"profit":true},{"date":"2025-06-30","value":44.81,"profit":true},{"date":"2025-09-30","value":49.35,"profit":true}]
Total Liabilities	16.21M	15.42M	8.24M	8.45M	7.00M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":95.13,"profit":true},{"date":"2025-03-31","value":50.84,"profit":true},{"date":"2025-06-30","value":52.15,"profit":true},{"date":"2025-09-30","value":43.21,"profit":true}]

Total Shareholders' equity
Common Stock	3.05M	3.06M	3.13M	3.13M	3.13M	[{"date":"2024-09-30","value":97.35,"profit":true},{"date":"2024-12-31","value":97.61,"profit":true},{"date":"2025-03-31","value":99.94,"profit":true},{"date":"2025-06-30","value":99.94,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(455.84M)	(462.88M)	(472.03M)	(486.64M)	(493.67M)	[{"date":"2024-09-30","value":-45583700000,"profit":false},{"date":"2024-12-31","value":-46288300000,"profit":false},{"date":"2025-03-31","value":-47202700000,"profit":false},{"date":"2025-06-30","value":-48664300000,"profit":false},{"date":"2025-09-30","value":-49366700000,"profit":false}]
Other Stockholders' Equity	536.43M	539.64M	544.27M	546.33M	548.04M	[{"date":"2024-09-30","value":97.88,"profit":true},{"date":"2024-12-31","value":98.47,"profit":true},{"date":"2025-03-31","value":99.31,"profit":true},{"date":"2025-06-30","value":99.69,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	72.54M	60.97M	60.08M	54.18M	46.60M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":84.05,"profit":true},{"date":"2025-03-31","value":82.83,"profit":true},{"date":"2025-06-30","value":74.69,"profit":true},{"date":"2025-09-30","value":64.24,"profit":true}]

Total Liabilities & Shareholders Equity	88.75M	76.39M	68.32M	62.63M	53.60M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":86.08,"profit":true},{"date":"2025-03-31","value":76.99,"profit":true},{"date":"2025-06-30","value":70.57,"profit":true},{"date":"2025-09-30","value":60.4,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(13.79%)	(10.52%)	(8.19%)	(14.68%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Non-current Assets	-	(19.57%)	(12.54%)	(14.97%)	(1.24%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(13.92%)	(10.56%)	(8.33%)	(14.42%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(2.53%)	(45.86%)	0.80%	(20.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-316.6,"profit":false},{"date":"2025-03-31","value":-5730.48,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-2547.94,"profit":false}]
Non-current Liabilities	-	(21.43%)	(52.70%)	20.56%	10.14%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-104.2,"profit":false},{"date":"2025-03-31","value":-256.28,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":49.33,"profit":true}]
Total Liabilities	-	(4.87%)	(46.56%)	2.58%	(17.15%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-188.32,"profit":false},{"date":"2025-03-31","value":-1801.41,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-663.6,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.26%	2.39%	-	0.06%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":10.99,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":2.68,"profit":true}]
Retained Earnings	-	1.55%	1.98%	3.10%	1.44%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":49.92,"profit":true},{"date":"2025-03-31","value":63.8,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":46.61,"profit":true}]
Other Stockholders' Equity	-	0.60%	0.86%	0.38%	0.31%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":69.97,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":44.28,"profit":true},{"date":"2025-09-30","value":36.53,"profit":true}]
Total Shareholders' equity	-	(15.95%)	(1.46%)	(9.83%)	(13.99%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(13.92%)	(10.56%)	(8.33%)	(14.42%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(38.62M)	(7.07M)	(48.82M)	(21.13M)	(32.83M)	[{"date":"2020-12-31","value":-3862381945,"profit":false},{"date":"2021-12-31","value":-707074797,"profit":false},{"date":"2022-12-31","value":-4882100000,"profit":false},{"date":"2023-12-31","value":-2113200000,"profit":false},{"date":"2024-12-31","value":-3283400000,"profit":false}]

Investing Activities
Net Investing Cash Flow	2.04M	(568.20K)	1.99M	(419.00K)	(699.00K)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-27.89,"profit":false},{"date":"2022-12-31","value":97.53,"profit":true},{"date":"2023-12-31","value":-20.57,"profit":false},{"date":"2024-12-31","value":-34.31,"profit":false}]

Financing Activities
Net Financing Cash Flow	47.34M	104.80M	200.00K	7.97M	46.15M	[{"date":"2020-12-31","value":45.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.19,"profit":true},{"date":"2023-12-31","value":7.61,"profit":true},{"date":"2024-12-31","value":44.03,"profit":true}]

Net Change in Cash	9.71M	95.59M	(59.22M)	(10.76M)	12.38M	[{"date":"2020-12-31","value":10.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-61.95,"profit":false},{"date":"2023-12-31","value":-11.26,"profit":false},{"date":"2024-12-31","value":12.95,"profit":true}]

Free Cash Flow
Free Cash Flow	(38.65M)	(7.79M)	(48.83M)	(21.55M)	(33.53M)	[{"date":"2020-12-31","value":-3864562465,"profit":false},{"date":"2021-12-31","value":-779280374,"profit":false},{"date":"2022-12-31","value":-4883400000,"profit":false},{"date":"2023-12-31","value":-2155100000,"profit":false},{"date":"2024-12-31","value":-3353300000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(81.69%)	590.46%	-	55.38%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-13.84,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":9.38,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(127.89%)	(449.70%)	-	66.83%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-191.38,"profit":false},{"date":"2022-12-31","value":-672.95,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	121.38%	(99.81%)	-	478.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":25.35,"profit":true},{"date":"2022-12-31","value":-20.85,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	884.86%	(161.95%)	-	(215.05%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-18.3,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-24.3,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(79.84%)	526.66%	-	55.60%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-15.16,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":10.56,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(7.52M)	(9.42M)	(8.33M)	(7.65M)	(7.31M)	[{"date":"2024-09-30","value":-751900000,"profit":false},{"date":"2024-12-31","value":-942000000,"profit":false},{"date":"2025-03-31","value":-832900000,"profit":false},{"date":"2025-06-30","value":-765100000,"profit":false},{"date":"2025-09-30","value":-730900000,"profit":false}]

Investing Activities
Net Investing Cash Flow	218.75	(618.00)	(320.00K)	(1.52K)	300.00K	[{"date":"2024-09-30","value":0.07,"profit":true},{"date":"2024-12-31","value":-0.21,"profit":false},{"date":"2025-03-31","value":-106.67,"profit":false},{"date":"2025-06-30","value":-0.51,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	(594.00K)	(40.00K)	422.00K	(134.00K)	-	[{"date":"2024-09-30","value":-140.76,"profit":false},{"date":"2024-12-31","value":-9.48,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-31.75,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	(6.91M)	(10.72M)	(7.32M)	(6.36M)	(7.43M)	[{"date":"2024-09-30","value":-690900000,"profit":false},{"date":"2024-12-31","value":-1072000000,"profit":false},{"date":"2025-03-31","value":-731900000,"profit":false},{"date":"2025-06-30","value":-635800000,"profit":false},{"date":"2025-09-30","value":-742700000,"profit":false}]

Free Cash Flow
Free Cash Flow	(8.22M)	(9.42M)	(8.65M)	(7.65M)	(7.31M)	[{"date":"2024-09-30","value":-821821800,"profit":false},{"date":"2024-12-31","value":-942038200,"profit":false},{"date":"2025-03-31","value":-864900000,"profit":false},{"date":"2025-06-30","value":-765100000,"profit":false},{"date":"2025-09-30","value":-730900000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	25.28%	(11.58%)	(8.14%)	(4.47%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-45.81,"profit":false},{"date":"2025-06-30","value":-32.2,"profit":false},{"date":"2025-09-30","value":-17.68,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(382.51%)	51679.94%	(99.52%)	(19823.87%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.74,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-0.19,"profit":false},{"date":"2025-09-30","value":-38.36,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(93.27%)	(1155.00%)	(131.75%)	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	-	55.16%	(31.73%)	(13.13%)	16.81%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-57.52,"profit":false},{"date":"2025-06-30","value":-23.8,"profit":false},{"date":"2025-09-30","value":30.48,"profit":true}]

Free Cash Flow
Free Cash Flow	-	14.63%	(8.19%)	(11.54%)	(4.47%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-55.98,"profit":false},{"date":"2025-06-30","value":-78.88,"profit":false},{"date":"2025-09-30","value":-30.56,"profit":false}]

Mereo BioPharma Group PLC ADR Ratios

Mereo BioPharma Group PLC ADR Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	MREO
Cash Ratio	8.09
Current Ratio	8.71

Mereo BioPharma Group PLC ADR Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	MREO
ROA (LTM)	-39.81%
ROE (LTM)	-69.79%

Mereo BioPharma Group PLC ADR Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	MREO
Debt Ratio Lower is generally better. Negative is bad.	0.13
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.87

Mereo BioPharma Group PLC ADR Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	MREO
Trailing PE	NM
Forward PE	NM
P/S (TTM)	123.71
P/B	1.33
Price/FCF	NM
EV/R	27.46
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Mereo BioPharma Group PLC ADR share price today?

Mereo BioPharma Group PLC ADR (MREO) share price today is $0.3719

Can Indians buy Mereo BioPharma Group PLC ADR shares?

Yes, Indians can buy shares of Mereo BioPharma Group PLC ADR (MREO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MREO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Mereo BioPharma Group PLC ADR be purchased?

Yes, you can purchase fractional shares of Mereo BioPharma Group PLC ADR (MREO) via the Vested app. You can start investing in Mereo BioPharma Group PLC ADR (MREO) with a minimum investment of $1.

How to invest in Mereo BioPharma Group PLC ADR shares from India?

You can invest in shares of Mereo BioPharma Group PLC ADR (MREO) via Vested in three simple steps:

Click on Sign Up or Invest in MREO stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Mereo BioPharma Group PLC ADR shares

What is Mereo BioPharma Group PLC ADR 52-week high and low stock price?

The 52-week high price of Mereo BioPharma Group PLC ADR (MREO) is $3.05. The 52-week low price of Mereo BioPharma Group PLC ADR (MREO) is $0.2.

What is Mereo BioPharma Group PLC ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Mereo BioPharma Group PLC ADR (MREO) is

What is Mereo BioPharma Group PLC ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Mereo BioPharma Group PLC ADR (MREO) is 1.33

What is Mereo BioPharma Group PLC ADR dividend yield?

The dividend yield of Mereo BioPharma Group PLC ADR (MREO) is 0.00%

What is the Market Cap of Mereo BioPharma Group PLC ADR?

The market capitalization of Mereo BioPharma Group PLC ADR (MREO) is $61.85M

What is Mereo BioPharma Group PLC ADR's stock symbol?

The stock symbol (or ticker) of Mereo BioPharma Group PLC ADR is MREO

How Can Investors Use Mereo BioPharma Group PLC ADR Share Price Data for Long-Term Investment Decisions?

Consider the share price of Mereo BioPharma Group PLC ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Mereo BioPharma Group PLC ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Mereo BioPharma Group PLC ADR shares for Indian investors?

When investing in Mereo BioPharma Group PLC ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Mereo BioPharma Group PLC ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Mereo BioPharma Group PLC ADR share price with other stocks in the same sector?

Rather than merely checking the share price of Mereo BioPharma Group PLC ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Mereo BioPharma Group PLC ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Mereo BioPharma Group PLC ADR Share Price

Mereo BioPharma Group PLC ADR Analyst Forecast

Mereo BioPharma Group PLC ADR Share Price Chart

Mereo BioPharma Group PLC ADR Key Stock Metrics

About Mereo BioPharma Group PLC ADR, Common Stock

Mereo BioPharma Group PLC ADR Stock Returns

Mereo BioPharma Group PLC ADR Financials

Mereo BioPharma Group PLC ADR Ratios

Mereo BioPharma Group PLC ADR Liquidity Ratios

Mereo BioPharma Group PLC ADR Asset Efficiency Ratios

Mereo BioPharma Group PLC ADR Liability Ratios

Mereo BioPharma Group PLC ADR Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Mereo BioPharma Group PLC ADR Share Price

Mereo BioPharma Group PLC ADR Analyst Forecast

Mereo BioPharma Group PLC ADR Share Price Chart

Mereo BioPharma Group PLC ADR Key Stock Metrics

About Mereo BioPharma Group PLC ADR, Common Stock

Mereo BioPharma Group PLC ADR Stock Returns

Mereo BioPharma Group PLC ADR Financials

Mereo BioPharma Group PLC ADR Ratios

Mereo BioPharma Group PLC ADR Liquidity Ratios

Mereo BioPharma Group PLC ADR Asset Efficiency Ratios

Mereo BioPharma Group PLC ADR Liability Ratios

Mereo BioPharma Group PLC ADR Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²